Bolt Biotherapeutics
BOLT
BOLT
62 hedge funds and large institutions have $165M invested in Bolt Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
63% less capital invested
Capital invested by funds: $449M → $165M (-$284M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
62
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$4.49M | |
2 | +$4.43M | |
3 | +$1.32M | |
4 |
BlackRock
New York
|
+$952K |
5 |
Holocene Advisors
New York
|
+$518K |
Top Sellers
1 | -$20.9M | |
2 | -$9.38M | |
3 | -$6.46M | |
4 |
ABG
Ally Bridge Group
New York
|
-$3.25M |
5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$2.35M |